foxo4-dri senolytic study FOXO4-DRI: The Peptide That Targets Zombie Cells and Aging – Revolution Health & Wellness FOXO4-DRI regulates endothelial cell senescence
Description
Research protocols prioritise pharmacokinetic precision, which subcutaneous dosing provides and oral dosing does not
These include mild or moderate nausea, diarrhea, vomiting, constipation, appetite loss, belching, heartburn, reflux and stomach pain
doi: 10.1016/j.rmed.2010.09.014
Treatment with methylcobalamin or hydroxocobalamin may unmask this condition
Brde P, Kampmann B
A trained provider will adjust your protocol based on how your symptoms respond, how the tissue heals, and in some cases, what shows up in your labs
